
Biodexa Pharmaceuticals Plc
BDRXHealthcare|Biotechnology|GB
$2.48
+0.07 (+2.88%)
DCF Value
$0.42
Tangible Book / Share
$0.19
Cash / Share
$0.17
Ownership Breakdown
81.2%
Float
116.6M
Shares Outstanding
94.7M
Float Shares
Insider Trades (12)
Last 4 quarters: 0 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Parker Stephen Barry | director | Mar 18, 2026 | OTHER | 576 | $475.00 | $273.6K | Form 4 |
| Merchant Ann Louise | director | Mar 18, 2026 | OTHER | 288 | $475.00 | $136.8K | Form 4 |
| Stamp Stephen Anthony | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 859 | $327.50 | $281.3K | Form 4 |
| Stamp Stephen Anthony | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 1,500 | $28.05 | $42.1K | Form 4 |
| Stamp Stephen Anthony | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 25,000 | $7.41 | $185.3K | Form 4 |
| Stamp Stephen Anthony | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 15,000 | $5.40 | $81.0K | Form 4 |
| de Vries Simon | director | Mar 18, 2026 | OTHER | 288 | $475.00 | $136.8K | Form 4 |
| Powell Fiona Mary | director, officer: Chief Financial Officer | Mar 18, 2026 | OTHER | 286 | $327.50 | $93.7K | Form 4 |
| Powell Fiona Mary | director, officer: Chief Financial Officer | Mar 18, 2026 | OTHER | 7,500 | $5.40 | $40.5K | Form 4 |
| Powell Fiona Mary | director, officer: Chief Financial Officer | Mar 18, 2026 | OTHER | 8,750 | $7.41 | $64.8K | Form 4 |
| Turton Simon | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Turton Simon | director | Mar 18, 2026 | OTHER | 288 | $475.00 | $136.8K | Form 4 |